HomeORGANIZATION
ORGANIZATION

FPMAJ Wants to Avoid Narrowing-Down of Premium-Eligible Products: Kamoya
(Jun.13.2016)

The Federation of Pharmaceutical Manufacturers’ Associations of Japan (FPMAJ) hopes to keep intact the current scope of on-patent drugs eligible for the so-called price maintenance premium, the group’s drug pricing affairs chief, Yoshiaki Kamoya, said on June 10 ...
(LOG IN FOR FULL STORY)

News Calendar